MedPath

Culturally Specific Interventions: African American Smokers

Phase 1
Completed
Conditions
Smoking
Smoking Cessation
Registration Number
NCT01811758
Lead Sponsor
University of Miami
Brief Summary

The investigators expect that a culturally specific group intervention targeting African American smokers will result in greater smoking cessation rates compared to a standard intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
345
Inclusion Criteria
  1. self-identification as African American
  2. current smoker of ≥ 5 cigarettes/day or expired CO level of ≥ 8 ppm;
  3. age 18-65;
  4. able to speak and read English;
  5. permanent contact information;
  6. access to transportation by public transit or car;
  7. no current behavioral or pharmacological treatment ;
  8. interest in quitting smoking; (9) have availability to attend sessions.
Exclusion Criteria
  1. enrolled in another cessation program,
  2. do not speak and read English,
  3. do not have access to transportation by car or bus to attend sessions,
  4. do not have childcare during session times,
  5. have contraindications for patch use (pregnant/breastfeeding),
  6. if they are in treatment for substance abuse (e.g., illicit drugs, alcohol abuse),
  7. if they endorse active addiction to another substance (e.g., illicit drugs or alcohol),
  8. if they have been diagnosed with an acute cardiac or respiratory condition;
  9. people identified as having a severe mental illness

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
7-day point prevalence abstinenceOverall effect at 12-months

Generalized linear mixed model of overall intervention effect.

Secondary Outcome Measures
NameTimeMethod
7-day point prevalence abstinence6-months

Trial Locations

Locations (1)

University of Miami

🇺🇸

Coral Gables, Florida, United States

University of Miami
🇺🇸Coral Gables, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.